UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000029695 |
|---|---|
| Receipt number | R000033930 |
| Scientific Title | Phase I/II study on the safety and efficacy of repeated administration of FIT039 transdermal patch for verrucas caused by human papilloma-virus |
| Date of disclosure of the study information | 2017/11/01 |
| Last modified on | 2020/12/11 18:05:46 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/10/24 18:35:36 | ||
| 2 | Update | 2017/11/30 13:53:34 | Trial characteristics_1 Developmental phase |
|
| 3 | Update | 2017/11/30 13:55:16 | Blinding Stratification Dynamic allocation Institution consideration Blocking Concealment |
|
| 4 | Update | 2017/11/30 14:03:22 | Name of primary person or sponsor Institute Institute Department Organization Organization Organization Division Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization Institutions |
|
| 5 | Update | 2017/11/30 14:04:05 | Recruitment status Anticipated trial start date |
|
| 6 | Update | 2017/12/01 13:42:49 | Address Address Address Organization1 Address1 Tel1 Email1 |
|
| 7 | Update | 2018/04/05 21:45:29 | Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 8 | Update | 2019/01/24 14:32:49 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 9 | Update | 2020/12/11 18:05:46 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Name of person sending information Organization Organization Address Address Tel |
